Home » Topics » Regulatory » Patents

Patents
RSS

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Feb. 15, 2005

Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature

Feb. 14, 2005

Novel antiinflammatory chalcones patented by AtheroGenics

Feb. 14, 2005

Bristol-Myers Squibb patent covers new antiinflammatory agents

Feb. 14, 2005

Aventis imparts new tubulin polymerization inhibitors for cancer therapy

Feb. 14, 2005

New anticoagulant agents reported by Bristol-Myers Squibb

Feb. 14, 2005

Three series of chemokine CCR4 receptor modulators claimed by AstraZeneca

Feb. 14, 2005

Novel PARP-1 inhibitors described by Altana Pharma in recent patent

Feb. 11, 2005

Novel protein tyrosine kinase inhibitors and their use as anticancer agents

Feb. 11, 2005

Anti-CD3 monoclonal antibodies with reduced immunogenicity claimed by Alexion

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...